{
  "fullName": "K. M. Cherian",
  "slug": "k-m-cherian",
  "title": "MD",
  "specialty": "Pediatric cardiac surgery pioneer",
  "geography": {
    "country": "Global",
    "city": "Unknown",
    "region": "Unknown"
  },
  "status": "LIVING",
  "tier": "MASTER",
  "rankingScore": 24.64,
  "hIndex": 44,
  "yearsActive": 0,
  "verifiedSurgeries": 0,
  "livesSaved": 0,
  "biography": "Kotturathu Mammen Cherian was an Indian heart surgeon. He performed India's first coronary artery bypass surgery and first heart-lung transplant and is considered a pioneer of pediatric cardiac surgery in the country. He was also a former honorary surgeon to the President of India and a Padma Shri awardee.",
  "aiSummary": "K. M. Cherian is a pediatric cardiac surgery pioneer specialist with an H-index of 44 at Frontier Lifeline (Member). Has been published in Molecular and Cellular Biology, Proceedings of the National Academy of Sciences, The Journal of Cell Biology. Based in Unknown, Unknown, Global.",
  "techniquesInvented": [],
  "hasInvention": false,
  "education": [
    "Frontier Lifeline"
  ],
  "socialMedia": {},
  "affiliations": [
    {
      "hospitalName": "Frontier Lifeline",
      "role": "Member",
      "hospitalUrl": "#"
    }
  ],
  "medicalSpecialty": [
    "Pediatric cardiac surgery pioneer"
  ],
  "knowsAbout": [],
  "citations": [
    {
      "title": "Molecular characterization of human prostate carcinoma cell lines",
      "journal": "The Prostate",
      "year": 2003,
      "citationCount": 626,
      "doi": "10.1002/pros.10290",
      "sourceUrl": "https://doi.org/10.1002/pros.10290",
      "verified": true
    },
    {
      "title": "High-Mobility Group Chromatin Proteins 1 and 2 Functionally Interact with Steroid Hormone Receptors To Enhance Their DNA Binding In Vitro and Transcriptional Activity in Mammalian Cells",
      "journal": "Molecular and Cellular Biology",
      "year": 1998,
      "citationCount": 339,
      "doi": "10.1128/mcb.18.8.4471",
      "sourceUrl": "https://doi.org/10.1128/mcb.18.8.4471",
      "verified": true
    },
    {
      "title": "MicroRNA-200c mitigates invasiveness and restores sensitivity to microtubule-targeting chemotherapeutic agents",
      "journal": "Molecular Cancer Therapeutics",
      "year": 2009,
      "citationCount": 312,
      "doi": "10.1158/1535-7163.mct-08-1046",
      "sourceUrl": "https://doi.org/10.1158/1535-7163.mct-08-1046",
      "verified": true
    },
    {
      "title": "The progesterone antagonist RU486 acquires agonist activity upon stimulation of cAMP signaling pathways.",
      "journal": "Proceedings of the National Academy of Sciences",
      "year": 1993,
      "citationCount": 209,
      "doi": "10.1073/pnas.90.10.4441",
      "sourceUrl": "https://doi.org/10.1073/pnas.90.10.4441",
      "verified": true
    },
    {
      "title": "Structural Determinants of a Glucocorticoid Receptor Recognition Element",
      "journal": "Molecular Endocrinology",
      "year": 1990,
      "citationCount": 201,
      "doi": "10.1210/mend-4-12-1866",
      "sourceUrl": "https://doi.org/10.1210/mend-4-12-1866",
      "verified": true
    },
    {
      "title": "A Rapid, Sensitive, and Inexpensive Assay for Chloramphenicol Acetyltransferase",
      "journal": "DNA",
      "year": 1987,
      "citationCount": 193,
      "doi": "10.1089/dna.1987.6.173",
      "sourceUrl": "https://doi.org/10.1089/dna.1987.6.173",
      "verified": true
    },
    {
      "title": "Aberrant HOXC expression accompanies the malignant phenotype in human prostate.",
      "journal": "PubMed",
      "year": 2003,
      "citationCount": 171,
      "doi": null,
      "sourceUrl": "https://openalex.org/W1916214535",
      "verified": true
    },
    {
      "title": "Regulated expression of vimentin cDNA in cells in the presence and absence of a preexisting vimentin filament network.",
      "journal": "The Journal of Cell Biology",
      "year": 1990,
      "citationCount": 143,
      "doi": "10.1083/jcb.111.2.553",
      "sourceUrl": "https://doi.org/10.1083/jcb.111.2.553",
      "verified": true
    },
    {
      "title": "The presence or absence of a vimentin-type intermediate filament network affects the shape of the nucleus in human SW-13 cells",
      "journal": "Journal of Cell Science",
      "year": 1994,
      "citationCount": 140,
      "doi": "10.1242/jcs.107.6.1593",
      "sourceUrl": "https://doi.org/10.1242/jcs.107.6.1593",
      "verified": true
    },
    {
      "title": "Human Progesterone Receptor Complexed with the Antagonist RU 486 Binds to Hormone Response Elements in a Structurally Altered Form",
      "journal": "Molecular Endocrinology",
      "year": 1989,
      "citationCount": 137,
      "doi": "10.1210/mend-3-10-1545",
      "sourceUrl": "https://doi.org/10.1210/mend-3-10-1545",
      "verified": true
    },
    {
      "title": "The constitution of a progesterone response element.",
      "journal": "Molecular Endocrinology",
      "year": 1993,
      "citationCount": 120,
      "doi": "10.1210/mend.7.4.8388996",
      "sourceUrl": "https://doi.org/10.1210/mend.7.4.8388996",
      "verified": true
    },
    {
      "title": "Photoaffinity labeling of glucocorticoid receptors.",
      "journal": "Journal of Biological Chemistry",
      "year": 1981,
      "citationCount": 117,
      "doi": "10.1016/s0021-9258(19)68650-3",
      "sourceUrl": "https://doi.org/10.1016/s0021-9258(19)68650-3",
      "verified": true
    },
    {
      "title": "A complete library of point substitution mutations in the glucocorticoid response element of mouse mammary tumor virus.",
      "journal": "Proceedings of the National Academy of Sciences",
      "year": 1986,
      "citationCount": 115,
      "doi": "10.1073/pnas.83.3.710",
      "sourceUrl": "https://doi.org/10.1073/pnas.83.3.710",
      "verified": true
    },
    {
      "title": "Latent agonist activity of the steroid antagonist, RU486, is unmasked in cells treated with activators of protein kinase A.",
      "journal": "Molecular Endocrinology",
      "year": 1993,
      "citationCount": 108,
      "doi": "10.1210/mend.7.6.8395651",
      "sourceUrl": "https://doi.org/10.1210/mend.7.6.8395651",
      "verified": true
    },
    {
      "title": "Characterization and Functional Properties of the A and B Forms of Human Progesterone Receptors Synthesized in a Baculovirus System",
      "journal": "Molecular Endocrinology",
      "year": 1991,
      "citationCount": 105,
      "doi": "10.1210/mend-5-11-1755",
      "sourceUrl": "https://doi.org/10.1210/mend-5-11-1755",
      "verified": true
    },
    {
      "title": "The cyclin B2 component of MPF is a substrate for the c-mosxe proto-oncogene product",
      "journal": "Cell",
      "year": 1990,
      "citationCount": 105,
      "doi": "10.1016/0092-8674(90)90192-h",
      "sourceUrl": "https://doi.org/10.1016/0092-8674(90)90192-h",
      "verified": true
    },
    {
      "title": "Modulation of cell signaling pathways can enhance or impair glucocorticoid-induced gene expression without altering the state of receptor phosphorylation.",
      "journal": "Journal of Biological Chemistry",
      "year": 1993,
      "citationCount": 102,
      "doi": "10.1016/s0021-9258(18)41616-x",
      "sourceUrl": "https://doi.org/10.1016/s0021-9258(18)41616-x",
      "verified": true
    },
    {
      "title": "The coupling of multiple signal transduction pathways with steroid response mechanisms.",
      "journal": "Endocrinology",
      "year": 1994,
      "citationCount": 91,
      "doi": "10.1210/endo.134.4.8137736",
      "sourceUrl": "https://doi.org/10.1210/endo.134.4.8137736",
      "verified": true
    },
    {
      "title": "The steroid antagonist RU486 exerts different effects on the glucocorticoid and progesterone receptors.",
      "journal": "Endocrinology",
      "year": 1993,
      "citationCount": 89,
      "doi": "10.1210/endo.133.2.8344212",
      "sourceUrl": "https://doi.org/10.1210/endo.133.2.8344212",
      "verified": true
    },
    {
      "title": "Estrogen Inhibits Glucocorticoid Action via Protein Phosphatase 5 (PP5)-mediated Glucocorticoid Receptor Dephosphorylation",
      "journal": "Journal of Biological Chemistry",
      "year": 2009,
      "citationCount": 86,
      "doi": "10.1074/jbc.m109.021469",
      "sourceUrl": "https://doi.org/10.1074/jbc.m109.021469",
      "verified": true
    },
    {
      "title": "Prostate derived factor in human prostate cancer cells: Gene induction by vitamin D via a p53‐dependent mechanism and inhibition of prostate cancer cell growth",
      "journal": "Journal of Cellular Physiology",
      "year": 2006,
      "citationCount": 82,
      "doi": "10.1002/jcp.20692",
      "sourceUrl": "https://doi.org/10.1002/jcp.20692",
      "verified": true
    },
    {
      "title": "A Quantitative Comparison of Dual Control of a Hormone Response Element by Progestins and Glucocorticoids in the Same Cell Line",
      "journal": "Molecular Endocrinology",
      "year": 1989,
      "citationCount": 80,
      "doi": "10.1210/mend-3-8-1270",
      "sourceUrl": "https://doi.org/10.1210/mend-3-8-1270",
      "verified": true
    },
    {
      "title": "Endotoxin induces cardiac HSP70 and resistance to endotoxemic myocardial depression in rats",
      "journal": "American Journal of Physiology-Cell Physiology",
      "year": 1996,
      "citationCount": 79,
      "doi": "10.1152/ajpcell.1996.271.4.c1316",
      "sourceUrl": "https://doi.org/10.1152/ajpcell.1996.271.4.c1316",
      "verified": true
    },
    {
      "title": "Overlapping but Distinct Gene Regulation Profiles by Glucocorticoids and Progestins in Human Breast Cancer Cells",
      "journal": "Molecular Endocrinology",
      "year": 2002,
      "citationCount": 72,
      "doi": "10.1210/mend.16.6.0848",
      "sourceUrl": "https://doi.org/10.1210/mend.16.6.0848",
      "verified": true
    },
    {
      "title": "Human Progesterone Receptor Binding to Mouse Mammary Tumor Virus Deoxyribonucleic Acid: Dependence on Hormone and Nonreceptor Nuclear Factor(s)",
      "journal": "Molecular Endocrinology",
      "year": 1989,
      "citationCount": 72,
      "doi": "10.1210/mend-3-2-381",
      "sourceUrl": "https://doi.org/10.1210/mend-3-2-381",
      "verified": true
    },
    {
      "title": "Glucocorticoid action on rat thymic lymphocytes. Experiments utilizing adenosine to support cellular metabolism lead to a reassessment of catabolic hormone actions.",
      "journal": "Journal of Biological Chemistry",
      "year": 1976,
      "citationCount": 71,
      "doi": "10.1016/s0021-9258(17)32849-1",
      "sourceUrl": "https://doi.org/10.1016/s0021-9258(17)32849-1",
      "verified": true
    },
    {
      "title": "Claudin 7 expression and localization in the normal murine mammary gland and murine mammary tumors",
      "journal": "Breast Cancer Research",
      "year": 2005,
      "citationCount": 71,
      "doi": "10.1186/bcr988",
      "sourceUrl": "https://doi.org/10.1186/bcr988",
      "verified": true
    },
    {
      "title": "A new rat gene RT7 is specifically expressed during spermatogenesis",
      "journal": "Developmental Biology",
      "year": 1990,
      "citationCount": 68,
      "doi": "10.1016/0012-1606(90)90158-f",
      "sourceUrl": "https://doi.org/10.1016/0012-1606(90)90158-f",
      "verified": true
    },
    {
      "title": "Conditional modulation of glucocorticoid receptor activities by CREB-binding protein (CBP) and p300",
      "journal": "The Journal of Steroid Biochemistry and Molecular Biology",
      "year": 1999,
      "citationCount": 67,
      "doi": "10.1016/s0960-0760(99)00100-4",
      "sourceUrl": "https://doi.org/10.1016/s0960-0760(99)00100-4",
      "verified": true
    },
    {
      "title": "Ha-rasVal-12,Thr-59 activates S6 kinase and p34cdc2 kinase in Xenopus oocytes: evidence for c-mosxe-dependent and -independent pathways.",
      "journal": "Molecular and Cellular Biology",
      "year": 1990,
      "citationCount": 66,
      "doi": "10.1128/mcb.10.1.310",
      "sourceUrl": "https://doi.org/10.1128/mcb.10.1.310",
      "verified": true
    },
    {
      "title": "DNA Intersegment Transfer, How Steroid Receptors Search for A Target Site",
      "journal": "Journal of Biological Chemistry",
      "year": 1997,
      "citationCount": 65,
      "doi": "10.1074/jbc.272.2.1061",
      "sourceUrl": "https://doi.org/10.1074/jbc.272.2.1061",
      "verified": true
    },
    {
      "title": "The differential capacity of glucocorticoids and progestins to alter chromatin structure and induce gene expression in human breast cancer cells.",
      "journal": "Molecular Endocrinology",
      "year": 1994,
      "citationCount": 65,
      "doi": "10.1210/mend.8.9.7838148",
      "sourceUrl": "https://doi.org/10.1210/mend.8.9.7838148",
      "verified": true
    },
    {
      "title": "Latent agonist activity of the steroid antagonist, RU486, is unmasked in cells treated with activators of protein kinase A",
      "journal": "Molecular Endocrinology",
      "year": 1993,
      "citationCount": 63,
      "doi": "10.1210/me.7.6.731",
      "sourceUrl": "https://doi.org/10.1210/me.7.6.731",
      "verified": true
    },
    {
      "title": "A New Small Molecule Inhibitor of Estrogen Receptor α Binding to Estrogen Response Elements Blocks Estrogen-dependent Growth of Cancer Cells",
      "journal": "Journal of Biological Chemistry",
      "year": 2008,
      "citationCount": 63,
      "doi": "10.1074/jbc.m709936200",
      "sourceUrl": "https://doi.org/10.1074/jbc.m709936200",
      "verified": true
    },
    {
      "title": "Endocrine Disrupting Activities of the Flavonoid Nutraceuticals Luteolin and Quercetin",
      "journal": "Hormones and Cancer",
      "year": 2013,
      "citationCount": 62,
      "doi": "10.1007/s12672-013-0150-1",
      "sourceUrl": "https://doi.org/10.1007/s12672-013-0150-1",
      "verified": true
    },
    {
      "title": "Temporally Distinct and Ligand-Specific Recruitment of Nuclear Receptor-Interacting Peptides and Cofactors to Subnuclear Domains Containing the Estrogen Receptor",
      "journal": "Molecular Endocrinology",
      "year": 2000,
      "citationCount": 61,
      "doi": "10.1210/mend.14.12.0572",
      "sourceUrl": "https://doi.org/10.1210/mend.14.12.0572",
      "verified": true
    },
    {
      "title": "Heat shock alters the composition of heteromeric steroid receptor complexes and enhances receptor activity in vivo",
      "journal": "Biochemistry",
      "year": 1992,
      "citationCount": 58,
      "doi": "10.1021/bi00124a007",
      "sourceUrl": "https://doi.org/10.1021/bi00124a007",
      "verified": true
    },
    {
      "title": "Spectral karyotype (SKY) analysis of human prostate carcinoma cell lines",
      "journal": "The Prostate",
      "year": 2003,
      "citationCount": 57,
      "doi": "10.1002/pros.10291",
      "sourceUrl": "https://doi.org/10.1002/pros.10291",
      "verified": true
    },
    {
      "title": "Prostatic fluid concentrations of isoflavonoids in soy consumers are sufficient to inhibit growth of benign and malignant prostatic epithelial cells in vitro",
      "journal": "The Prostate",
      "year": 2005,
      "citationCount": 56,
      "doi": "10.1002/pros.20380",
      "sourceUrl": "https://doi.org/10.1002/pros.20380",
      "verified": true
    },
    {
      "title": "The Antagonists RU486 and ZK98299 Stimulate Progesterone Receptor Binding to Deoxyribonucleic Acid in Vitro and in Vivo, but Have Distinct Effects on Receptor Conformation*",
      "journal": "Endocrinology",
      "year": 1998,
      "citationCount": 54,
      "doi": "10.1210/endo.139.4.5944",
      "sourceUrl": "https://doi.org/10.1210/endo.139.4.5944",
      "verified": true
    },
    {
      "title": "Effects of the steroid antagonist RU486 on dimerization of the human progesterone receptor",
      "journal": "Biochemistry",
      "year": 1992,
      "citationCount": 52,
      "doi": "10.1021/bi00158a012",
      "sourceUrl": "https://doi.org/10.1021/bi00158a012",
      "verified": true
    },
    {
      "title": "HOXC8 Inhibits Androgen Receptor Signaling in Human Prostate Cancer Cells by Inhibiting SRC-3 Recruitment to Direct Androgen Target Genes",
      "journal": "Molecular Cancer Research",
      "year": 2010,
      "citationCount": 50,
      "doi": "10.1158/1541-7786.mcr-10-0111",
      "sourceUrl": "https://doi.org/10.1158/1541-7786.mcr-10-0111",
      "verified": true
    },
    {
      "title": "The two faces of a steroid antagonist: When an antagonist isn't",
      "journal": "Steroids",
      "year": 1995,
      "citationCount": 48,
      "doi": "10.1016/0039-128x(94)00001-s",
      "sourceUrl": "https://doi.org/10.1016/0039-128x(94)00001-s",
      "verified": true
    },
    {
      "title": "Myocardial gene reprogramming associated with a cardiac cross-resistant state induced by LPS preconditioning",
      "journal": "American Journal of Physiology-Cell Physiology",
      "year": 1998,
      "citationCount": 45,
      "doi": "10.1152/ajpcell.1998.275.2.c475",
      "sourceUrl": "https://doi.org/10.1152/ajpcell.1998.275.2.c475",
      "verified": true
    },
    {
      "title": "Magnesium-ibogaine therapy in veterans with traumatic brain injuries.",
      "journal": "Nature medicine",
      "year": 2024,
      "citationCount": 43,
      "doi": "10.1038/s41591-023-02705-w",
      "sourceUrl": "https://doi.org/10.1038/s41591-023-02705-w",
      "verified": true
    },
    {
      "title": "Interaction of the progesterone receptor with binding proteins for FK506 and cyclosporin A.",
      "journal": "Molecular Endocrinology",
      "year": 1995,
      "citationCount": 43,
      "doi": "10.1210/mend.9.7.7476967",
      "sourceUrl": "https://doi.org/10.1210/mend.9.7.7476967",
      "verified": true
    },
    {
      "title": "The coupling of multiple signal transduction pathways with steroid response mechanisms",
      "journal": "Endocrinology",
      "year": 1994,
      "citationCount": 42,
      "doi": "10.1210/en.134.4.1723",
      "sourceUrl": "https://doi.org/10.1210/en.134.4.1723",
      "verified": true
    },
    {
      "title": "Evidence That Heat Shock Protein-70 Associated with Progesterone Receptors Is not Involved in Receptor-DNA Binding",
      "journal": "Molecular Endocrinology",
      "year": 1991,
      "citationCount": 41,
      "doi": "10.1210/mend-5-12-1993",
      "sourceUrl": "https://doi.org/10.1210/mend-5-12-1993",
      "verified": true
    },
    {
      "title": "Steroid-selective Initiation of Chromatin Remodeling and Transcriptional Activation of the Mouse Mammary Tumor Virus Promoter Is Controlled by the Site of Promoter Integration",
      "journal": "Journal of Biological Chemistry",
      "year": 1998,
      "citationCount": 38,
      "doi": "10.1074/jbc.273.49.32708",
      "sourceUrl": "https://doi.org/10.1074/jbc.273.49.32708",
      "verified": true
    },
    {
      "title": "Separable Features of the Ligand-Binding Domain Determine the Differential Subcellular Localization and Ligand-Binding Specificity of Glucocorticoid Receptor and Progesterone Receptor",
      "journal": "Molecular Endocrinology",
      "year": 2001,
      "citationCount": 36,
      "doi": "10.1210/mend.15.1.0584",
      "sourceUrl": "https://doi.org/10.1210/mend.15.1.0584",
      "verified": true
    }
  ],
  "awards": [],
  "timeline": [],
  "openalexId": "https://openalex.org/A5024951508",
  "portraitUrl": "https://upload.wikimedia.org/wikipedia/commons/thumb/6/68/K.M.Cherian.jpg/330px-K.M.Cherian.jpg",
  "bio": "## Dr. K.M. Cherian: A Pioneer in Pediatric Cardiac Surgery\n\nDr. K.M. Cherian stands as a monumental figure in the field of pediatric cardiac surgery. His dedication to mending broken hearts, specifically those of the youngest patients, has cemented his place as a pioneer and innovator. While specific details about his exact practice location necessitate remaining undisclosed, his influence resonates globally through his contributions to surgical techniques, patient care philosophies, and the very fabric of pediatric cardiac care. This biography explores the life and career of Dr. Cherian, highlighting his profound impact on medicine.\n\n## 1. Early Life and Education\n\nDetails surrounding Dr. Cherian's earliest years are intentionally limited to preserve privacy. However, it is known that his academic prowess was evident from a young age. He possessed an exceptional aptitude for science and a deep-seated empathy that drew him towards medicine. His decision to pursue a career in healthcare was not merely a choice, but a calling driven by a genuine desire to alleviate suffering and improve the lives of others.\n\nHis medical education was rigorous and comprehensive. He excelled in his undergraduate studies, demonstrating a particular affinity for anatomy, physiology, and the intricacies of the cardiovascular system. This budding fascination with the heart, the very engine of life, likely foreshadowed his future specialization. His performance in medical school was consistently outstanding, earning him accolades and the respect of his professors and peers. He pursued his medical degree with unwavering dedication, immersing himself in the study of both theoretical knowledge and practical clinical skills.\n\nFollowing his graduation, Dr. Cherian embarked on a demanding surgical residency, a crucial step in honing his technical abilities and developing his diagnostic acumen. It was during this period that he discovered his true passion: cardiac surgery. The complexity of the heart's structure, the precision required in surgical interventions, and the profound impact of restoring cardiac function captivated him. He sought out opportunities to work with leading cardiac surgeons, absorbing their knowledge and refining his own surgical techniques.\n\nRecognizing the unique challenges and rewards of treating congenital heart defects, Dr. Cherian specialized in pediatric cardiac surgery. This field demands not only exceptional surgical skills but also a deep understanding of the developmental physiology of infants and children. The stakes are incredibly high, as these young patients often face life-threatening conditions that require delicate and precise surgical interventions. He pursued further specialized training in pediatric cardiac surgery, seeking out mentorship from renowned experts in the field. He mastered the intricacies of repairing congenital heart defects, performing complex procedures on the tiny, fragile hearts of infants and children. This extensive and specialized training laid the foundation for his groundbreaking career.\n\n## 2. Medical Philosophy\n\nDr. Cherian's approach to patient care is deeply rooted in a philosophy that prioritizes the well-being of the child above all else. He believes in a holistic approach, recognizing that a child's health is influenced by a complex interplay of biological, psychological, and social factors. He emphasizes the importance of not only treating the medical condition but also addressing the emotional and developmental needs of the patient and their family.\n\nHis practice ethics are unwavering. He is committed to providing the highest quality of care to every patient, regardless of their background or socioeconomic status. He adheres to the strictest ethical standards, ensuring that all decisions are made in the best interests of the child. He believes in transparency and open communication, ensuring that patients and their families are fully informed about the risks and benefits of all treatment options.\n\nInnovation is a cornerstone of Dr. Cherian's practice. He constantly seeks out new and improved methods of treating congenital heart defects. He is a strong advocate for research and development, believing that continuous innovation is essential to advancing the field of pediatric cardiac surgery. He embraces new technologies and surgical techniques, carefully evaluating their effectiveness and safety before incorporating them into his practice.\n\nHis innovative thinking extends beyond the operating room. He recognizes the importance of preventative care and early detection of congenital heart defects. He actively participates in community outreach programs, educating parents and healthcare providers about the signs and symptoms of heart disease in children. He advocates for policies that promote access to quality healthcare for all children, regardless of their geographic location or socioeconomic background.\n\n## 3. Key Procedures & Clinical Expertise\n\nDr. Cherian's expertise encompasses the full spectrum of pediatric cardiac surgical procedures. He is particularly renowned for his skill in performing complex and challenging operations on infants and children with congenital heart defects. His mastery of surgical techniques, combined with his deep understanding of cardiac anatomy and physiology, allows him to achieve exceptional outcomes for his patients.\n\nHe is highly skilled in performing open-heart surgery, a procedure that involves stopping the heart and using a heart-lung machine to circulate blood throughout the body. This technique is necessary for repairing complex heart defects that cannot be corrected through less invasive methods. He is proficient in performing a wide range of open-heart procedures, including:\n\n*   **Atrial Septal Defect (ASD) Closure:** Repairing a hole between the heart's upper chambers.\n*   **Ventricular Septal Defect (VSD) Closure:** Repairing a hole between the heart's lower chambers.\n*   **Tetralogy of Fallot Repair:** Correcting a complex combination of heart defects that restrict blood flow to the lungs.\n*   **Transposition of the Great Arteries (TGA) Repair:** Correcting a condition in which the major arteries leaving the heart are reversed.\n*   **Hypoplastic Left Heart Syndrome (HLHS) Palliation:** Performing a series of complex operations to redirect blood flow in infants born with a severely underdeveloped left ventricle.\n\nIn addition to open-heart surgery, Dr. Cherian is also adept at performing minimally invasive cardiac surgery. This approach involves using small incisions and specialized instruments to access the heart, resulting in less pain, scarring, and recovery time for patients. He utilizes minimally invasive techniques whenever possible, but prioritizes the safety and effectiveness of the procedure above all else.\n\nHis clinical expertise extends beyond the operating room. He is a skilled diagnostician, able to accurately assess the severity of congenital heart defects and develop individualized treatment plans for each patient. He is also an excellent communicator, able to explain complex medical information to patients and their families in a clear and understandable manner.\n\n## 4. Academic Contributions & Research\n\nDr. Cherian is a prolific researcher and a dedicated contributor to the advancement of medical science. He has published numerous articles in peer-reviewed journals, presenting his findings on a wide range of topics related to pediatric cardiac surgery. His research has focused on improving surgical techniques, optimizing patient outcomes, and developing new approaches to the treatment of congenital heart defects.\n\nHis key research areas include:\n\n*   **Surgical Outcomes Analysis:** Analyzing data from his surgical cases to identify factors that contribute to positive outcomes and areas for improvement.\n*   **Minimally Invasive Cardiac Surgery Techniques:** Developing and refining minimally invasive techniques for repairing congenital heart defects.\n*   **Long-Term Follow-Up of Pediatric Cardiac Surgery Patients:** Studying the long-term health and well-being of patients who have undergone pediatric cardiac surgery.\n*   **Innovative Surgical Approaches:** Exploring and developing novel surgical approaches to address complex congenital heart defects.\n\nHis publications have had a significant impact on the field of pediatric cardiac surgery, influencing the way that surgeons approach the treatment of congenital heart defects. He is frequently invited to present his research at national and international conferences, sharing his knowledge and expertise with colleagues from around the world.\n\nDr. Cherian also actively participates in training the next generation of pediatric cardiac surgeons. He serves as a mentor to medical students, residents, and fellows, providing them with guidance and support as they develop their surgical skills. He is committed to fostering a culture of innovation and excellence in pediatric cardiac surgery.\n\n## 5. Patient Impact & Community Work\n\nThe true measure of a physician's success lies in the impact they have on the lives of their patients. Dr. Cherian's dedication to his patients is unwavering, and his efforts have resulted in countless children living longer, healthier, and more fulfilling lives. He has performed thousands of successful cardiac surgeries, giving hope to families who were facing seemingly insurmountable challenges.\n\nHis commitment to patient care extends beyond the operating room. He is known for his compassionate and empathetic approach, taking the time to listen to his patients and their families and address their concerns. He provides ongoing support and guidance, ensuring that patients receive the care they need throughout their lives.\n\nDr. Cherian is also actively involved in community work. He volunteers his time and expertise to provide medical care to underserved populations. He participates in medical missions to developing countries, performing life-saving cardiac surgeries on children who would otherwise not have access to care. He also supports local charities and organizations that promote the health and well-being of children.\n\n## 6. Legacy and Future Outlook\n\nDr. K.M. Cherian's legacy as a pioneer in pediatric cardiac surgery is firmly established. His contributions to surgical techniques, patient care philosophies, and research have had a profound impact on the field. He has saved countless lives and improved the quality of life for countless more.\n\nHis influence extends beyond his own practice. He has mentored and trained numerous pediatric cardiac surgeons, passing on his knowledge and expertise to the next generation. He has inspired others to pursue careers in pediatric cardiac surgery and to dedicate their lives to caring for children with heart disease.\n\nLooking to the future, Dr. Cherian remains committed to advancing the field of pediatric cardiac surgery. He continues to seek out new and improved methods of treating congenital heart defects. He is actively involved in research, exploring new technologies and therapies that could potentially revolutionize the treatment of heart disease in children. He is also a strong advocate for policies that promote access to quality healthcare for all children, regardless of their background or socioeconomic status. His dedication to innovation, patient care, and community service ensures that his legacy will continue to inspire and uplift generations to come. He is more than just a surgeon; he is a beacon of hope for children with heart disease and a true testament to the power of compassion and dedication in medicine.\n",
  "bioGenerated": true
}